C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/44 (2006.01)
Patent
CA 2573779
The present invention relates to a method for determining an increased risk of mortality or of a cardiac and/or vascular event in a patient, comprising: - determining the sPLA2 activity of said patient, - comparing said activity to a predetermined value, a higher sPLA2 activity of said patient as compared to said predetermined value being indicative of an increased risk of mortality or of a cardiac and/or vascular event.
La présente invention concerne une technique permettant de déterminer un risque accru de mortalité ou d'événement cardiaque et/ou vasculaire chez un patient, qui consiste : à déterminer l'activité sPLA2 de ce patient, à comparer cette activité a une valeur prédéterminée, une activités PLA2 de ce patient supérieur à la valeur prédéterminée indiquant un risque accru de mortalité ou d'événement cardiaque et/ou vasculaire.
Benessiano Joelle
Freyssinet Jean-Marie
Mallat Ziad
Steg Philippe Gabriel
Tedgui Alain
Goudreau Gage Dubuc
I.n.s.e.r.m. (institut National de La Sante Et de La Recherche M
LandOfFree
Cardiovascular prognostic and diagnostic marker does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiovascular prognostic and diagnostic marker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiovascular prognostic and diagnostic marker will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1343472